Sponsored by: Investment Center

Something new in your business?  Click here to submit your business press release

Chamber Corner | Main Street News | Job Hunt | Classifieds | Calendar | Illinois Lottery 

Vertex drug label to warn on possible fatal rash

Send a link to a friend

[December 20, 2012]  CAMBRIDGE, Mass. (AP) -- The Food and Drug Administration is attaching a black box warning to the Vertex Pharmaceuticals hepatitis C treatment Incivek over a potentially fatal rash.

The FDA says patients taking the pill in combination with two other treatments should stop immediately if they develop a rash that grows worse or comes with symptoms like a fever, diarrhea or mouth sores.

Patients taking this drug can develop a rash that covers more than half the body.

Vertex Pharmaceuticals Inc. says the drug's labeling had already warned that patients with a serious skin reaction should stop. The new warning is much more prominent on the label.

Incivek is taken with the pill ribavirin and interferon, which is given by injection. A black box warning is the most serious form of safety warning.

[Associated Press]

Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.





< Top Stories index

Back to top


News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries

Community | Perspectives | Law & Courts | Leisure Time | Spiritual Life | Health & Fitness | Teen Scene
Calendar | Letters to the Editor